Portugal will acquire Pfizer antiviral, DGS warns that it does not replace the vaccine
The director-general of Health said this Friday that Portugal will acquire Pfizer’s antivir against covid-19, without confirming availability or when it is available in Portugal, but underlined that the drug does not replace the vaccine.
“courses that are offered to the press at the moment, which will not be released daily”, are confirmed for Graça, which the Government proposes to reduce the number of entertainment centers.
According to Graça Freitas, Portugal is already submitting reservation requests, through Infarmed and the Directorate-General for Health, but the person in charge has not been confirmed when it will be available.
Asked if the antiviral can replace an eventual fourth dose of the vaccine against the 19-vaccine, the director-general stressed that “they have really signed different different”.
“The vaccine that is used, preferably, for primary prevention. This anti-alunoviral, with certain characteristics, and to prevent the progression of the disease”description.
As for the reinforcement of severity, Graça Freitas still dose” and the term “continue to be applicable, in a selective regimen that is seasonal, unlike the fourth regimen against the flu.
Currently, it has already received a booster dose from millions of people, or equivalent to 85% of the eligible population, with about 950,000 people remaining to be vaccinated, said the Assistant Secretary of State and Health at the same press conference in Lisbon.
Asked how many vaccines are not safe, since many vaccines are not safe, since many vaccines are not safe.
“Just as they are used to make shares or for resale purposes, this being an acquisition mechanism also articulated together with the European community.